Skip to main content
PMC home page
Signal Transduction and Targeted Therapy logoLink to Signal Transduction and Targeted Therapy
. 2021 Mar 12;6:120. doi: 10.1038/s41392-021-00533-3

Correction: Small molecule induces mitochondrial fusion for neuroprotection via targeting CK2 without affecting its conventional kinase activity

Ke-Wu Zeng 1,#, Jing-Kang Wang 1,#, Li-Chao Wang 1, Qiang Guo 1, Ting-Ting Liu 1, Fu-Jiang Wang 1, Na Feng 1, Xiao-Wen Zhang 1, Li-Xi Liao 1, Mei-Mei Zhao 1, Dan Liu 2, Yong Jiang 1, Pengfei Tu 1,✉
PMCID: PMC7955056  PMID: 33712568

Correction to: Signal Transduction and Targeted Therapy 10.1038/s41392-020-00447-6, published online 19 February 2021

In the process of collating the published data, the editors noticed one inadvertent mistake occurred during the production process in Fig. 6 that needs to be corrected.1 The correct data are provided as follows. The key findings of the article are not affected by these corrections.

Fig. 6.

Fig. 6

Open in a new tab

i, j Swimming performance analysis for ECH and IWP-2 neuroprotection in ischemia/reperfusion-induced zebrafishes. Data are expressed as the mean ± SD. ##P < 0.01 vs control group. *P < 0.05, **P < 0.01 vs MCAO group. NS not significant

The original article has been corrected.

Footnotes

These authors contributed equally: Ke-Wu Zeng, Jing-Kang Wang

Reference

  • 1.Zeng KW, et al. Small molecule induces mitochondrial fusion for neuroprotection via targeting CK2 without affecting its conventional kinase activity. Signal Transduct. Target Ther. 2021;6:71. doi: 10.1038/s41392-020-00447-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Signal Transduction and Targeted Therapy are provided here courtesy of Nature Publishing Group

RESOURCES